Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126193461 | 12619346 | 1 | I | 20160725 | 20160803 | 20160803 | EXP | IT-MYLANLABS-2016M1030701 | MYLAN | EDOARDO RAPOSIO, NICOLO BERTOZZI, LUISA QUARTA, GRIGNAFFINI EUGENIO. A CASE OF NEUROLEPTIC MALIGNANT SYNDROME AFTER BREAST REDUCTION SURGERY IN A SCHIZOPHRENIC PATIENT. SURG CHRON. 2016;21(1):41-43 | 0.00 | Y | 0.00000 | 20160803 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126193461 | 12619346 | 1 | SS | QUETIAPINE. | QUETIAPINE | 1 | 100 MG OT | Y | U | 0 | |||||||||
| 126193461 | 12619346 | 2 | PS | FENTANYL. | FENTANYL | 1 | 500 MG, UNK | 76258 | 500 | MG | |||||||||
| 126193461 | 12619346 | 3 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 2 MG, UNK | 0 | 2 | MG | |||||||||
| 126193461 | 12619346 | 4 | SS | ATROPINE. | ATROPINE | 1 | 0.5 MG, UNK | 0 | .5 | MG | |||||||||
| 126193461 | 12619346 | 5 | SS | PROPOFOL. | PROPOFOL | 1 | 200 MG, UNK | 0 | 200 | MG | |||||||||
| 126193461 | 12619346 | 6 | SS | MORPHINE | MORPHINE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 126193461 | 12619346 | 7 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Oral | 40 GTT, UNK | Y | U | 0 | 40 | GTT | ||||||
| 126193461 | 12619346 | 8 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 20 GTT, UNK | U | U | 0 | 20 | GTT | ||||||
| 126193461 | 12619346 | 9 | SS | CISATRACURIUM. | CISATRACURIUM | 1 | 29 MG, UNK | 0 | 29 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126193461 | 12619346 | 1 | Schizophrenia |
| 126193461 | 12619346 | 2 | General anaesthesia |
| 126193461 | 12619346 | 3 | General anaesthesia |
| 126193461 | 12619346 | 4 | General anaesthesia |
| 126193461 | 12619346 | 5 | General anaesthesia |
| 126193461 | 12619346 | 6 | General anaesthesia |
| 126193461 | 12619346 | 7 | Schizophrenia |
| 126193461 | 12619346 | 8 | Schizophrenia |
| 126193461 | 12619346 | 9 | General anaesthesia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126193461 | 12619346 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126193461 | 12619346 | Neuroleptic malignant syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |